BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31679053)

  • 1. The genetic landscape of the human solute carrier (SLC) transporter superfamily.
    Schaller L; Lauschke VM
    Hum Genet; 2019 Dec; 138(11-12):1359-1377. PubMed ID: 31679053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnogeographic and inter-individual variability of human ABC transporters.
    Xiao Q; Zhou Y; Lauschke VM
    Hum Genet; 2020 May; 139(5):623-646. PubMed ID: 32206879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic in silico discovery of novel solute carrier-like proteins from proteomes.
    Gyimesi G; Hediger MA
    PLoS One; 2022; 17(7):e0271062. PubMed ID: 35901096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population.
    Mir A; Almudhry M; Alghamdi F; Albaradie R; Ibrahim M; Aldurayhim F; Alhedaithy A; Alamr M; Bawazir M; Mohammad S; Abdelhay S; Bashir S; Housawi Y
    Hum Genet; 2022 Jan; 141(1):81-99. PubMed ID: 34797406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guide to plasma membrane solute carrier proteins.
    Pizzagalli MD; Bensimon A; Superti-Furga G
    FEBS J; 2021 May; 288(9):2784-2835. PubMed ID: 32810346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
    Rives ML; Javitch JA; Wickenden AD
    Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
    Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
    Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Identification and Evolutionary Trends of the Solute Carrier Superfamily in Arthropods.
    Denecke SM; Driva O; Luong HNB; Ioannidis P; Linka M; Nauen R; Geibel S; Vontas J
    Genome Biol Evol; 2020 Aug; 12(8):1429-1439. PubMed ID: 32681801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
    Dolberg AM; Reichl S
    Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of the solute carrier gene family in the mouse brain.
    Dahlin A; Royall J; Hohmann JG; Wang J
    J Pharmacol Exp Ther; 2009 May; 329(2):558-70. PubMed ID: 19179540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variability and population diversity of the human SLCO (OATP) transporter family.
    Zhang B; Lauschke VM
    Pharmacol Res; 2019 Jan; 139():550-559. PubMed ID: 30359687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational exploration of fold atlas for human solute carrier proteins.
    Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
    Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ABCs of membrane transporters in health and disease (SLC series): introduction.
    Hediger MA; Clémençon B; Burrier RE; Bruford EA
    Mol Aspects Med; 2013; 34(2-3):95-107. PubMed ID: 23506860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species.
    Höglund PJ; Nordström KJ; Schiöth HB; Fredriksson R
    Mol Biol Evol; 2011 Apr; 28(4):1531-41. PubMed ID: 21186191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and update of the human solute carrier (SLC) gene superfamily.
    He L; Vasiliou K; Nebert DW
    Hum Genomics; 2009 Jan; 3(2):195-206. PubMed ID: 19164095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters.
    Sreedharan S; Stephansson O; Schiöth HB; Fredriksson R
    Gene; 2011 Jun; 478(1-2):11-8. PubMed ID: 21044875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.
    Chen S; Sutiman N; Zhang CZ; Yu Y; Lam S; Khor CC; Chowbay B
    Drug Metab Rev; 2016 Nov; 48(4):502-540. PubMed ID: 27546072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.
    Park JE; Ryoo G; Lee W
    AAPS J; 2017 Nov; 19(6):1643-1655. PubMed ID: 28971357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies.
    Ceder MM; Fredriksson R
    Gene; 2022 Jan; 809():146033. PubMed ID: 34673204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.